← Evidence map

ReviewCA: a cancer journal for clinicians

Novel clinical trial designs emerging from the molecular reclassification of cancer.

Mina Nikanjam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2025
2026
cites it
Full record →Abstract, authors, funding and every citing paper · PMID 39841128